A detailed history of Act Capital Management, LLC transactions in Icad Inc stock. As of the latest transaction made, Act Capital Management, LLC holds 205,000 shares of ICAD stock, worth $344,400. This represents 0.59% of its overall portfolio holdings.

Number of Shares
205,000
Previous 205,000 -0.0%
Holding current value
$344,400
Previous $820,000 47.44%
% of portfolio
0.59%
Previous 1.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$3.02 - $4.56 $270,290 - $408,119
-89,500 Reduced 30.39%
205,000 $820,000
Q1 2022

May 11, 2022

SELL
$3.92 - $7.48 $116,032 - $221,408
-29,600 Reduced 9.13%
294,500 $1.31 Million
Q4 2021

Feb 03, 2022

BUY
$6.7 - $11.38 $667,320 - $1.13 Million
99,600 Added 44.37%
324,100 $2.33 Million
Q3 2021

Nov 16, 2021

BUY
$10.11 - $17.56 $25,275 - $43,900
2,500 Added 1.13%
224,500 $2.41 Million
Q2 2021

Aug 16, 2021

BUY
$14.9 - $20.82 $3.31 Million - $4.62 Million
222,000 New
222,000 $3.84 Million

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $42.6M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.